$NRX Pharmaceuticals (NRXP.US)$ NRX Pharmaceuticals (NASDAQ:...
NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.12) by 41.67 percent. This is a 50 percent increase over losses of $(0.14) per share from the same period last year.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
BuyingHighSellingLow :